Post-Treatment Head and Neck Cancer Care : National Audit and Analysis of Current Practice in the United Kingdom
© 2020 John Wiley & Sons Ltd..
OBJECTIVES: We aimed to audit current United Kingdom (UK) practice of Head and Neck Cancer (HNC) post-treatment surveillance against national guidelines and determine the outcomes of these practices in detecting recurrence.
DESIGN: National cross-sectional study of current HNC surveillance practice.
SETTING: UK HNC outpatient departments.
PARTICIPANTS: HNC patients reviewed for post-treatment surveillance.
MAIN OUTCOME MEASURES: Compliance with UK multidisciplinary guidelines and rates of cancer recurrence detection by time, clinic type and symptoms.
RESULTS: Data were analysed from 5,123 consultations across 89 UK centres. 30% of consultations were in dedicated multidisciplinary clinics, with input from allied health professionals (AHPs) available on the day in 23% of all consultations. Recurrence was suspected in 344 consultations and investigated with MRI in 29.6% (n = 102) and PET-CT in 14.2% (n = 49). Patient education regarding recurrence symptoms, and smoking and alcohol advice, was provided in 20.4%, 6.2% and 5.3% of cases, respectively. Rates of recurrence detected were 35% in expedited appointments and 5.2% in planned follow-ups (P = .0001). Of the expedited appointments, 63% were initiated by patients and 37% by clinicians. Recurrence was higher in those with new symptoms (7.1% versus 2.2%). The strongest predictors of recurrence were dyspnoea (positive predictive value (PPV)=16.2%), neck pain (PPV = 10.4%) and mouth/throat pain (PPV = 9.2%).
CONCLUSIONS: Dedicated multidisciplinary clinics comprise a minority of consultations for HNC surveillance in the UK, with low availability of AHPs. PET-CT and MRI were underutilised for the investigation of suspected recurrence. There may be scope for greater emphasis on patient education and consequent patient-initiated symptom-driven follow-up.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:46 |
---|---|
Enthalten in: |
Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery - 46(2021), 1 vom: 05. Jan., Seite 284-294 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
INTEGRATE (The UK ENT Trainee Research Network) [VerfasserIn] |
---|
Links: |
---|
Themen: |
Audit |
---|
Anmerkungen: |
Date Completed 15.04.2022 Date Revised 27.05.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1111/coa.13616 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM313101957 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM313101957 | ||
003 | DE-627 | ||
005 | 20231225145838.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1111/coa.13616 |2 doi | |
028 | 5 | 2 | |a pubmed24n1043.xml |
035 | |a (DE-627)NLM313101957 | ||
035 | |a (NLM)32734679 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a INTEGRATE (The UK ENT Trainee Research Network) |e verfasserin |4 aut | |
245 | 1 | 0 | |a Post-Treatment Head and Neck Cancer Care |b National Audit and Analysis of Current Practice in the United Kingdom |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 15.04.2022 | ||
500 | |a Date Revised 27.05.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2020 John Wiley & Sons Ltd. | ||
520 | |a OBJECTIVES: We aimed to audit current United Kingdom (UK) practice of Head and Neck Cancer (HNC) post-treatment surveillance against national guidelines and determine the outcomes of these practices in detecting recurrence | ||
520 | |a DESIGN: National cross-sectional study of current HNC surveillance practice | ||
520 | |a SETTING: UK HNC outpatient departments | ||
520 | |a PARTICIPANTS: HNC patients reviewed for post-treatment surveillance | ||
520 | |a MAIN OUTCOME MEASURES: Compliance with UK multidisciplinary guidelines and rates of cancer recurrence detection by time, clinic type and symptoms | ||
520 | |a RESULTS: Data were analysed from 5,123 consultations across 89 UK centres. 30% of consultations were in dedicated multidisciplinary clinics, with input from allied health professionals (AHPs) available on the day in 23% of all consultations. Recurrence was suspected in 344 consultations and investigated with MRI in 29.6% (n = 102) and PET-CT in 14.2% (n = 49). Patient education regarding recurrence symptoms, and smoking and alcohol advice, was provided in 20.4%, 6.2% and 5.3% of cases, respectively. Rates of recurrence detected were 35% in expedited appointments and 5.2% in planned follow-ups (P = .0001). Of the expedited appointments, 63% were initiated by patients and 37% by clinicians. Recurrence was higher in those with new symptoms (7.1% versus 2.2%). The strongest predictors of recurrence were dyspnoea (positive predictive value (PPV)=16.2%), neck pain (PPV = 10.4%) and mouth/throat pain (PPV = 9.2%) | ||
520 | |a CONCLUSIONS: Dedicated multidisciplinary clinics comprise a minority of consultations for HNC surveillance in the UK, with low availability of AHPs. PET-CT and MRI were underutilised for the investigation of suspected recurrence. There may be scope for greater emphasis on patient education and consequent patient-initiated symptom-driven follow-up | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a audit | |
650 | 4 | |a cancer | |
650 | 4 | |a guidelines | |
650 | 4 | |a head and neck | |
650 | 4 | |a recurrence | |
650 | 4 | |a surveillance | |
650 | 4 | |a treatment | |
700 | 1 | |a Ellis, M |e investigator |4 oth | |
700 | 1 | |a Garas, G |e investigator |4 oth | |
700 | 1 | |a Hardman, J |e investigator |4 oth | |
700 | 1 | |a Kahn, M |e investigator |4 oth | |
700 | 1 | |a Mehanna, H |e investigator |4 oth | |
700 | 1 | |a Smith, M E |e investigator |4 oth | |
700 | 1 | |a Swords, C |e investigator |4 oth | |
700 | 1 | |a Wilson, G |e investigator |4 oth | |
700 | 1 | |a Hone, R |e investigator |4 oth | |
700 | 1 | |a Siau, R |e investigator |4 oth | |
700 | 1 | |a Hampton, T |e investigator |4 oth | |
700 | 1 | |a Mclaren, O |e investigator |4 oth | |
700 | 1 | |a Fleming, J |e investigator |4 oth | |
700 | 1 | |a Biggs, T |e investigator |4 oth | |
700 | 1 | |a Fussey, J |e investigator |4 oth | |
700 | 1 | |a Farr, M |e investigator |4 oth | |
700 | 1 | |a Steven, R |e investigator |4 oth | |
700 | 1 | |a Yiannakis, D |e investigator |4 oth | |
700 | 1 | |a Adams, J |e investigator |4 oth | |
700 | 1 | |a Wright, B |e investigator |4 oth | |
700 | 1 | |a Davies, K |e investigator |4 oth | |
700 | 1 | |a Dick, D |e investigator |4 oth | |
700 | 1 | |a Adams, M |e investigator |4 oth | |
700 | 1 | |a Jones, H |e investigator |4 oth | |
700 | 1 | |a Myuran, T |e investigator |4 oth | |
700 | 1 | |a Goh, S |e investigator |4 oth | |
700 | 1 | |a Dowling, M |e investigator |4 oth | |
700 | 1 | |a Sinnott, J |e investigator |4 oth | |
700 | 1 | |a Hardy, A |e investigator |4 oth | |
700 | 1 | |a Halliday, E |e investigator |4 oth | |
700 | 1 | |a Virk, J |e investigator |4 oth | |
700 | 1 | |a Ahmed, F |e investigator |4 oth | |
700 | 1 | |a Walton, J |e investigator |4 oth | |
700 | 1 | |a van Beugen, B |e investigator |4 oth | |
700 | 1 | |a Hope, N |e investigator |4 oth | |
700 | 1 | |a Edmond, M |e investigator |4 oth | |
700 | 1 | |a Lau, K |e investigator |4 oth | |
700 | 1 | |a Ahmed, T |e investigator |4 oth | |
700 | 1 | |a Nair, D |e investigator |4 oth | |
700 | 1 | |a Varadharajan, K |e investigator |4 oth | |
700 | 1 | |a Lin, D |e investigator |4 oth | |
700 | 1 | |a Ferguson, L |e investigator |4 oth | |
700 | 1 | |a Mahalingam, S |e investigator |4 oth | |
700 | 1 | |a Kamhieh, Y |e investigator |4 oth | |
700 | 1 | |a Afiq Slim, M |e investigator |4 oth | |
700 | 1 | |a Tornari, T |e investigator |4 oth | |
700 | 1 | |a Abdel-Rahim, A |e investigator |4 oth | |
700 | 1 | |a Hutson, K |e investigator |4 oth | |
700 | 1 | |a Millington, A |e investigator |4 oth | |
700 | 1 | |a Moorhouse, T |e investigator |4 oth | |
700 | 1 | |a Farrar, E |e investigator |4 oth | |
700 | 1 | |a Doumas, S |e investigator |4 oth | |
700 | 1 | |a Kamel, U |e investigator |4 oth | |
700 | 1 | |a Coyle, P |e investigator |4 oth | |
700 | 1 | |a McAnerney, D |e investigator |4 oth | |
700 | 1 | |a Mirza, O |e investigator |4 oth | |
700 | 1 | |a Leopard, D |e investigator |4 oth | |
700 | 1 | |a Saunders, T |e investigator |4 oth | |
700 | 1 | |a McMurran, L |e investigator |4 oth | |
700 | 1 | |a Johnstone, L |e investigator |4 oth | |
700 | 1 | |a Oremule, T |e investigator |4 oth | |
700 | 1 | |a Bates, J |e investigator |4 oth | |
700 | 1 | |a Iacovidou, A |e investigator |4 oth | |
700 | 1 | |a Upile, N |e investigator |4 oth | |
700 | 1 | |a Chessman, R |e investigator |4 oth | |
700 | 1 | |a Mcleod, R |e investigator |4 oth | |
700 | 1 | |a Milner, T |e investigator |4 oth | |
700 | 1 | |a Cheong, R |e investigator |4 oth | |
700 | 1 | |a Gaunt, A |e investigator |4 oth | |
700 | 1 | |a To, K |e investigator |4 oth | |
700 | 1 | |a Tse, A |e investigator |4 oth | |
700 | 1 | |a Yap, D |e investigator |4 oth | |
700 | 1 | |a Noon, E |e investigator |4 oth | |
700 | 1 | |a Cresswell, M |e investigator |4 oth | |
700 | 1 | |a Mallick, A S |e investigator |4 oth | |
700 | 1 | |a Crookes, W |e investigator |4 oth | |
700 | 1 | |a Corner, C |e investigator |4 oth | |
700 | 1 | |a Walker, N |e investigator |4 oth | |
700 | 1 | |a Ricks, R |e investigator |4 oth | |
700 | 1 | |a Healy, S |e investigator |4 oth | |
700 | 1 | |a Kendall, W |e investigator |4 oth | |
700 | 1 | |a Fragkiadakis, G |e investigator |4 oth | |
700 | 1 | |a Conroy, K |e investigator |4 oth | |
700 | 1 | |a Pervez, A |e investigator |4 oth | |
700 | 1 | |a Caton, N |e investigator |4 oth | |
700 | 1 | |a Balakumar, R |e investigator |4 oth | |
700 | 1 | |a Smith, C |e investigator |4 oth | |
700 | 1 | |a Waters, A |e investigator |4 oth | |
700 | 1 | |a Advani, R |e investigator |4 oth | |
700 | 1 | |a Shaker, M |e investigator |4 oth | |
700 | 1 | |a Schecter, E |e investigator |4 oth | |
700 | 1 | |a Liu, Z W |e investigator |4 oth | |
700 | 1 | |a Karamali, K |e investigator |4 oth | |
700 | 1 | |a Alvi, S |e investigator |4 oth | |
700 | 1 | |a Cosway, B |e investigator |4 oth | |
700 | 1 | |a Thorley, D |e investigator |4 oth | |
700 | 1 | |a Williams, M |e investigator |4 oth | |
700 | 1 | |a Bijoor, P |e investigator |4 oth | |
700 | 1 | |a Anwar, B |e investigator |4 oth | |
700 | 1 | |a Hamilton, N |e investigator |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery |d 2005 |g 46(2021), 1 vom: 05. Jan., Seite 284-294 |w (DE-627)NLM154030759 |x 1749-4486 |7 nnns |
773 | 1 | 8 | |g volume:46 |g year:2021 |g number:1 |g day:05 |g month:01 |g pages:284-294 |
856 | 4 | 0 | |u http://dx.doi.org/10.1111/coa.13616 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 46 |j 2021 |e 1 |b 05 |c 01 |h 284-294 |